Acute procoagulant stress response as a dynamic measure of allostatic load in Alzheimer caregivers

Annals of Behavioral Medicine

Volumn 26, Issue 1, 2003, Pages 42-48

  Von Känel, Roland ^a,b   Dimsdale, Joel E ^a   Patterson, Thomas L ^a,c   Grant, Igor ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ETH ZURICH   (Switzerland)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCOAGULANT; THROMBIN ANTITHROMBIN COMPLEX; VON WILLEBRAND FACTOR;

ADAPTATION; AGE; AGED; ARTICLE; CAREGIVER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HEMOSTASIS; HUMAN; LIFE EVENT; MALE; SCORING SYSTEM; SELF REPORT; SMOKING; SPOUSE; STRESS; TASK PERFORMANCE; WEIGHT BEARING;

EID: 18144436476     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15324796abm2601_06     Document Type: Article

References (47)

1. McEwen BS, Stellar E: Stress and the individual. Mechanisms leading to disease. Archives of Internal Medicine. 1993, 153:2093-2101.
2. McEwen BS: Stress, adaption, and disease. Allostasis and allostatic load. Annals of the New York Academy of Sciences. 1998, 840:33-44.
3. Seeman TE, McEwen BS, Rowe JW, Singer BH: Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proceedings of the National Academy of Sciences of the United States of America. 2001, 98:4770-4775.
4. McEwen BS, Seeman T: Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Annals of the New York Academy of Sciences. 1999, 896:30-47.
5. Davies MJ: The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thrombosis Research. 1996, 82:1-32.
6. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000, 20:1262-1275.
7. von Känel R, Dimsdale JE: Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. European Journal of Haematology. 2000, 65:357-369.
8. von Känel R, Mills PJ, Fainman C, Dimsdale JE: Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosomatic Medicine. 2001, 63:531-544.
9. von Känel R, Mills PJ, Ziegler MG, Dimsdale JE: The effect of β2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. American Heart Journal. 2002, 144:68-72.
10. Heim C, Newport DJ, Heit S, et al.: Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. Journal of the Americal Medical Association. 2000, 284:592-597.
11. Grant I: Caregiving may be hazardous to your health. Psychosomatic Medicine. 1999, 61:420-423.
12. Irwin M, Brown M, Patterson T, et al.: Neuropeptide Y and natural killer cell activity: Findings in depression and Alzheimer caregiver stress. The Federation of American Societies for Experimental Biology Journal. 1991, 5:3100-3107.
13. Mills PJ, Ziegler MG, Patterson T, et al.: Plasma catecholamine and lymphocyte β2-adrenergic receptor alterations in elderly Alzheimer caregivers under stress. Psychosomatic Medicine. 1997, 59:251-256.
14. Mills PJ, Yu H, Ziegler MG, Patterson TL, Grant I: Vulnerable caregivers of Alzheimer's diseases patients have a deficit in circulationg CD62L-T lymphocytes. Psychosomatic Medicine. 1999, 61:168-174.
15. Shaw WS, Patterson TL, Ziegler MG, et al.: Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. Journal of Psychosomatic Research. 1999, 46:215-227.
16. Cacioppo JT, Burleson MH, Poehlmann KM, et al.: Autonomic and neuroendocrine responses to mild psychological stressors: Effects of chronic stress on older women. Annals of Behavioral Medicine. 2000, 22:140-148.
17. von Känel R, Dimsdale JE, Ziegler MG, et al.: Effect of acute psychological stress on the hypercoagulable state in subjects (spousal caregivers of patients with Alzheimer's disease) with coronary or cerebrovascular disease and/or systemic hypertension. American Journal of Cardiology. 2001, 87:1405-1408.
18. von Känel R, Dimsdale JE, Patterson TL, Grant I: Association of negative life-event stress with coagulation activity in elderly Alzheimer caregivers. Psychosomatic Medicine. 2003, 65:145-150.
19. Schulz R, Beach SR: Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. Journal of the American Medical Association. 1999, 282:2215-2219.
20. Russo J, Vitaliano PP: Life events as correlates of burden in spouse caregivers of persons with Alzheimer's disease. Experimental Aging Research. 1995, 21:273-294.
21. Pelzer H, Schwarz A, Heimburger N: Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thrombosis and Haemostasis. 1988, 59:101-106.
22. Lip GY, Lowe GD: Fibrin D-dimer: A useful clinical marker of thrombogenesis? Clinical Science. 1995, 89:205-214.
23. Lijnen HR, Collen D: Endothelium in hemostasis and thrombosis. Progress in Cardiovascular Diseases. 1997, 39:343-350.
24. Meyer D, Girma JP: von Willebrand factor: structure and function. Thrombosis and Haemostasis. 1993, 70:99-104.
25. Hamsten A, de Faire U, Walldius G, et al.: Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987, 2:3-9.
26. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH: Endogenous tissue type plasminogen activator and risk of myocardial infarction. Lancet. 1993, 341:1165-1168.
27. Jansson JH, Nilsson TK, Johnson O: von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10-year follow up of survivors of acute myocardial infarction. Heart. 1998, 80:334-337.
28. Li YH, Teng JK, Tsai WC, et al.: Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction. Journal of the American College of Cardiology. 1999, 33:1543-1548.
29. Danesh J, Whincup P, Walker M, et al.: Fibrin d-dimer and coronary heart disease: prospective study and meta-analysis. Circulation. 2001, 103:2323-2327.
30. Folsom AR: Hemostatic risk factors for atherotrombotic disease: An epidemiologic view. Thrombosis and Haemostasis. 2001, 86:366-373.
31. Fareed J, Hoppensteadt DA, Leya F, et al.: Thrombogenesis in myocardial infarction and related syndromes: The role of molecular markers in diagnosis and management. Clinical and Applied Thrombosis and Hemostasis. 1999, 5:78-91.
32. Shaw WS, Patterson TL, Semple SJ, et al.: Longitudinal analysis of multiple indicators of health decline among spousal caregivers. Annals of Behavioral Medicine. 1997, 19:101-109.
33. Brown G, Harris TJ: Life Events and Illnesses. New York: Guilford, 1989.
34. Grant I, Brown GW, Harris T, et al.: Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 1989, 52:8-13.
35. Saab PG, Matthews KA, Stoney CM, McDonald RH: Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors. Psychophysiology. 1989, 26:270-280.
36. Short PE, Williams CE, Picken AM, Hill FG: Factor VIII related antigen: an improved enzyme immunoassay. Medical Laboratory Sciences. 1982, 39:351-355.
37. Hevey D, McGee HM, Fitzgerald D, Horgan JH: Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients. European Journal of Applied Physiology. 2000, 83:344-348.
38. Ranby M, Nguyen G, Scarabin PY, Samama M: Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay. Thrombosis and Haemostasis. 1989, 61:409-414.
39. Schulz R, O'Brien AT, Bookwala J, Fleissner K: Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. Gerontologist 1995, 35:771-791.
40. Blann AD, Naqvi T, Waite M, McCollum CN: von Willebrand factor and endothelial damage in essential hypertension. Journal of Human Hypertension. 1993, 7:107-111.
41. Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM: C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis? Arteriosclerosis, Thrombosis, and Vascular Biology. 2001, 21:603-610.
42. Folsom AR, Aleksic N, Park E, et al: Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2001, 21:611-617.
43. Brunner EJ, Marmot MG, White IR, et al.: Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study. Atherosclerosis. 1993, 102:195-207.
44. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ: Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 1993, 342:1076-1079.
45. Meigs JB, Mittleman MA, Nathan DM, et al.: Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. Journal of the American Medical Association. 2000, 283:221-228.
46. Catto AJ, Grant PJ: Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis. Blood Coagulation and Fibrinolysis. 1995, 6:497-510.
47. Lip GY, Blann AD: Does hypertension confer a prothrombotic state? Virchow's triad revisited. Circulation. 2000, 101:218-220.